Legend Biotech Corp (LEGN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US52490G1022
Legend Biotech Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.03 bn USD |
| Gross profit | 631.80 m USD |
| Operating income | -136.50 m USD |
| EBIT | -136.00 m USD |
| Net income | -296.80 m USD |
| Diluted EPS – continuing operations | -1.61 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Legend Biotech Corp
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
More stocks
- Societatea Nationala de Transport Gaze Naturale Transgaz SA (TGN.RO)
- ZIM Integrated Shipping Services Ltd (ZIM)
- Interparfums SA (ITP.PA)
- Qingdao Gon Technology Co Ltd (002768.SZ)
- Ventia Services Group Ltd (VNT.AX)
- Hualan Biological EngineeringInc (002007.SZ)
- Huber+Suhner AG (HUBN.SW)
- Iren SpA (IRE.MI)
- NCR Atleos Corp (NATL)
- AbCellera Biologics Inc. (ABCL)
- QinetiQ Group PLC (QQ.L)
- Hunan Valin Steel Co Ltd (000932.SZ)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.